Attorneys have played a role in the FDA’s evolving approach to enforcement

Armand Rossetti

Contributor

1 CommentPrint ArticleSubscribe

Today’s headlines are replete with news about the FDA’s recent commitment to stronger enforcement. I suspect that attorneys’ public comments over the years, concerning the FDA’s seeming lack of vigilance, strategy, timeliness, and visibility have reached the eyes and ears of someone who is going to act efficiently and effectively in the public interest.

I was quite pleased to learn that FDA Commissioner, Margaret Hamburg, MD, after only eight weeks on the job, has boldly advanced an agenda that if followed will give the current FDA a welcome “makeover.”

Some readers may remember Commissioner Hamburg’s appearance on Charlie Rose to discuss the Ebola virus. Dr. Hamburg is eminently qualified for her position. In fact, the US Senate gave Dr. Hamburg unanimous approval to become FDA Commissioner. For a more comprehensive idea of Dr. Hamburg's plans for the FDA, please view the webcast of Commissioner Hamburg’s address before the Food and Drug Law Institute (FDLI).

If Commissioner Hamburg can ensure improved consumer safety without undue delay, because of red tape laden road blocks, it will definitely be a consumers’ "dream come true."